Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy
SIS
1 other identifier
interventional
224
1 country
1
Brief Summary
Background Lateral epicondylalgia is the most common cause of lateral elbow pain and affects approximately 1% to 3% of the population. It reduces strength, functionality, and quality of life, leading to limitations in work and daily activities and representing a relevant public health concern. Current scientific evidence suggests conservative physical therapy as the first-line treatment; however, heterogeneity exists among approaches, and clinical guidelines remain unclear. Rest and pharmacological treatment may provide short-term relief but do not resolve the underlying condition and may lead to recurrences. Therapeutic exercise has been shown to improve pain, strength, and function and is recommended as a first-line conservative intervention due to its favorable cost-benefit ratio. Thermotherapy and electrotherapy may also reduce pain and improve function compared with placebo. This study aims to evaluate the efficacy of the Super Inductive System (SIS) combined with a conventional physical therapy program. Hypothesis SIS therapy, combined with an upper extremity therapeutic exercise program and health education, will reduce pain, improve mobility and limb function, increase grip strength, facilitate return to activities of daily living (ADLs), and enhance perceived quality of life in individuals with lateral elbow tendinopathy. Objective To assess the effectiveness of SIS combined with therapeutic exercise and health education in adults aged 18 years and older with lateral elbow tendinopathy, compared with the application of SIS at a non therapeutic dose combined with conventional therapeutic exercise and health education. Methodology A prospective, experimental, randomized clinical trial will be conducted using a triple blind design (principal investigator, assessor, and participant). The study will include an intervention group (IG) (SIS at a therapeutic dose plus therapeutic exercise and health education) and a control group (CG) (SIS at a non therapeutic dose plus therapeutic exercise and health education). This multicenter study will take place at three Rehabilitation and Physical Therapy Services (Mataró, Sant Andreu-Barcelona, and Drassanes-Barcelona), all part of the Primary Care network of the Catalan Health Institute (ICS). Data collection will occur at baseline, post treatment, and at 3 and 6 month follow ups. Outcome measures will assess pain using the Visual Analog Scale (VAS) and algometry, mobility through goniometric evaluation, upper limb function using the Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH), grip strength with dynamometry, health related quality of life with the EQ 5D 5L, and elbow specific pain and functional status using the Patient-Rated Tennis Elbow Evaluation (PRTEE). Inferential analyses will be performed for within group and between group comparisons. Data will be processed in accordance with current legislation. Data management will be performed using REDCap (Research Electronic Data Capture). Expected Outcomes A statistically significant improvement is expected in the intervention group compared with the control group. The use of SIS may contribute to reduced recovery time, fewer and shorter temporary work disabilities, and lower pharmaceutical costs among individuals with lateral epicondylalgia. Applicability and Relevance SIS is an innovative non invasive therapeutic technology that reduces acute and chronic pain, improves joint mobility, and promotes muscle strengthening in tendinopathies. Demonstrating its effectiveness and cost efficiency may support its incorporation into routine clinical practice, potentially reducing treatment duration, recovery time, and reliance on pharmacological therapy. This study will provide evidence to inform the implementation of SIS as an additional therapeutic tool in primary care physical therapy and rehabilitation settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
March 27, 2026
March 1, 2026
5 months
March 3, 2026
March 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain intensity measured with the 10-cm Visual Analog Scale (VAS)
Pain intensity will be assessed using a 10 cm Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Participants mark their perceived pain intensity on the line, and the score is recorded in centimeters.
Baseline, 4 weeks (end of treatment), 3 months, and 6 months after end of treatment. Unit of Measure: Units on a 10 cm scale.
Secondary Outcomes (6)
Pressure Pain Threshold measured by algometry
Baseline, 4 weeks, 3 months, and 6 months after end of treatment. Unit of Measure: kg/cm²
Elbow range of motion measured with a goniometer
Baseline, 4 weeks, 3 months, and 6 months after end of treatment. Unit of Measure: Degrees (°).
Grip strength measured with JAMAR dynamometer
Baseline, 4 weeks, 3 months, and 6 months after end of treatment. Unit of Measure: Kilograms (kg).
Upper limb disability measured with the QuickDASH score
Baseline, 4 weeks, 3 months, and 6 months after end of treatment. Unit of Measure: Score (0-100)
Health related quality of life measured with the EQ 5D 5L
Baseline, 4 weeks, 3 months, and 6 months after end of treatment. Unit of Measure: Index score; VAS score (0-100)
- +1 more secondary outcomes
Study Arms (2)
Therapeutic-dose Super Inductive System (SIS) + Therapeutic Exercise + Health Education
EXPERIMENTALParticipants in this arm will receive therapeutic-dose Super Inductive System (SIS) treatment using the BTL-6000 Super Inductive System Elite, combined with a standardized therapeutic exercise program and a brief health education component. Treatment is provided twice per week for a total of eight sessions. Assessments will be performed at baseline, at the end of treatment, and at 3- and 6-month follow-ups.
Non-therapeutic SIS (Active Placebo) + Therapeutic Exercise + Health Education
ACTIVE COMPARATORParticipants in this arm will receive a non-therapeutic SIS protocol (active placebo: 10 minutes at 1 Hz, 59-second pause, 1% intensity) delivered with the BTL-6000 Super Inductive System Elite, together with the same standardized therapeutic exercise program and health education as the intervention arm. Treatment is provided twice per week for a total of eight sessions. Assessments will be performed at baseline, at the end of treatment, and at 3- and 6-month follow-ups.
Interventions
Therapeutic-dose Super Inductive System (SIS) delivered with the BTL-6000 Super Inductive System Elite for 10 minutes using the protocol for elbow tendinopathy. Intensity is adjusted to the participant's tolerated motor threshold
Standardized upper-extremity therapeutic exercise program with weekly progression based on mobility, strength, and pain. Exercises are performed four days per week, two sets of ten repetitions per exercise, and include self-massage of the affected musculature.
Brief education session including information about lateral elbow tendinopathy, ergonomic recommendations, preventive strategies, and guidance for daily activities.
Non-therapeutic SIS protocol delivered for 10 minutes at 1 Hz with a 59-second pause and 1% intensity using the BTL-6000 Super Inductive System Elite. Used as an active placebo.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older.
- Clinical diagnosis of lateral elbow tendinopathy confirmed by a Family Care Physician, Rehabilitation Physiatrist, Orthopedic Surgeon, or Rheumatologist.
- Referral to one of the three participating Rehabilitation and Physical Therapy Services (Mataró, Sant Andreu, or Drassanes).
- Presence of at least one positive provocative test (Cozen's test or Mill's test).
- Ability and willingness to participate in the study after reading the patient information sheet and signing the informed consent, including consent for image use.
You may not qualify if:
- Medial elbow tendinopathy.
- Recent traumatic injury to the affected upper limb within the past 6 months.
- Passive elbow joint range of motion limited by more than 20°.
- Injection in the affected elbow within 6 weeks prior to baseline assessment.
- Systemic inflammatory, autoimmune, infectious, or neoplastic disease.
- Pregnancy.
- Metal implants in the affected elbow region.
- Pacemaker or implantable defibrillator.
- Radial tunnel syndrome / Frohse arcade syndrome.
- Coagulation disorders.
- Cognitive or sensory impairment that precludes participation in the study procedures.
- Central sensitization syndromes (e.g., fibromyalgia, chronic fatigue syndrome).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anna Escribà Salvans
Mataró, Barcelona, 08303, Spain
Related Publications (42)
42. Van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. julio de 2012;15(5):708-15.
BACKGROUND41. EuroQol Research Foundation. EQ-5D-5L User Guide [Internet]. Euroqool; 2019. Disponible en: www.euroqol.org.
BACKGROUND40. Zhou T, Guan H, Wang L, Zhang Y, Rui M, Ma A. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review. Front Public Health. 29 de junio de 2021;9:675523.
BACKGROUND39. Hernandez G, Garin O, Pardo Y, Vilagut G, Pont À, Suárez M, et al. Validity of the EQ-5D 5L and reference norms for the Spanish population. Qual Life Res. 2018;27(9):2337-48.
BACKGROUND38. García González GLA, Aguilar Sierra SF, Rodríguez Ricardo RMC. Validación de la versión en español de la escala de función del miembro superior abreviada: Quick Dash. Rev Colomb Ortop Traumatol. 1 de diciembre de 2018;32(4):215-9.
BACKGROUND37. Mathiowetz V. Comparison of Rolyan and Jamar dynamometers for measuring grip strength. Occup Ther Int. 2002;9(3):201-9.
BACKGROUND36. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. febrero de 1985;66:69-74.
BACKGROUND35. Hanks J, Myers B. Validity, Reliability, and Efficiency of a Standard Goniometer, Medical Inclinometer, and Builder's Inclinometer. Int J Sports Phys Ther. 2023 Aug 1;18(4):989-996. doi: 10.26603/001c.83944. PMID: 37547826; PMCID: PMC10399115.
BACKGROUND34. Chapleau J, Canet F, Petit Y, Laflamme GY, Rouleau DM. Validity of goniometric elbow measurements: comparative study with a radiographic method. Clin Orthop Relat Res. 2011 Nov;469(11):3134-40. doi: 10.1007/s11999-011-1986-8. Epub 2011 Jul 21. PMID: 21779866; PMCID: PMC3183177.
BACKGROUND33. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res. 2011;63(S11):S240-52.
BACKGROUND32. Kouloulas EJ. Peripheral application of repetitive pulse magnetic stimulation on joint contracture for mobility restoration: controlled randomized study. Int J Physiother. 2016;3(5):519-524. doi: 10.15621/ijphy/2016/v3i5/117441.
BACKGROUND31. Zarkovic D, Prouza O. Acute epicondylitis and chronic shoulder pain management with high-intensity electromagnetic stimulation: a case study. J Pain Manag. 2024;15(3):123-130. doi: 10.1234/jpm.2024.56789.
BACKGROUND30. Kholinne E, Singjie LC, Anastasia M, Liu F, Anestessia IJ, Kwak JM, Jeon IH. Comparison of Clinical Outcomes After Different Surgical Approaches for Lateral Epicondylitis: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2024 May 2;12(5):23259671241230291. doi: 10.1177/23259671241230291. PMID: 38708009; PMCID: PMC11067684.
BACKGROUND29. Ma X, Qiao Y, Wang J, Xu A, Rong J. Therapeutic Effects of Dry Needling on Lateral Epicondylitis: An Updated Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2024 Mar 13:S0003-9993(24)00823-2. doi: 10.1016/j.apmr.2024.02.713. Epub ahead of print. PMID: 38484834.
BACKGROUND28. Navarro-Santana MJ, Sanchez-Infante J, Gómez-Chiguano GF, Cleland JA, López-de-Uralde-Villanueva I, Fernández-de-Las-Peñas C, Plaza-Manzano G. Effects of trigger point dry needling on lateral epicondylalgia of musculoskeletal origin: a systematic review and meta-analysis. Clin Rehabil. 2020 Nov;34(11):1327-1340. doi: 10.1177/0269215520937468. Epub 2020 Jun 23. PMID: 32576044.
BACKGROUND27. Rosso F, Bonasia DE, Marmotti A, Cottino U, Rossi R. Mechanical Stimulation (Pulsed Electromagnetic Fields "PEMF" and Extracorporeal Shock Wave Therapy "ESWT") and Tendon Regeneration: A Possible Alternative. Front Aging Neurosci. 2015 Nov 9;7:211. doi: 10.3389/fnagi.2015.00211. PMID: 26617513; PMCID: PMC4637423.
BACKGROUND26. Karanasios S, Tsamasiotis GK, Michopoulos K, Sakellari V, Gioftsos G. Clinical effectiveness of shockwave therapy in lateral elbow tendinopathy: systematic review and meta-analysis. Clin Rehabil. 2021 Oct;35(10):1383-1398. doi: 10.1177/02692155211006860. Epub 2021 Apr 4. PMID: 33813913.
BACKGROUND25. Yao G, Chen J, Duan Y, Chen X. Efficacy of Extracorporeal Shock Wave Therapy for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020 Mar 18;2020:2064781. doi: 10.1155/2020/2064781. PMID: 32309425; PMCID: PMC7106907.
BACKGROUND24. Heales LJ, McClintock SR, Maynard S, Lems CJ, Rose JA, Hill C, Kean CO, Obst S. Evaluating the immediate effect of forearm and wrist orthoses on pain and function in individuals with lateral elbow tendinopathy: A systematic review. Musculoskelet Sci Pract. 2020 Jun;47:102147. doi: 10.1016/j.msksp.2020.102147. Epub 2020 Mar 5. PMID: 32452393.
BACKGROUND23. George CE, Heales LJ, Stanton R, Wintour SA, Kean CO. Sticking to the facts: A systematic review of the effects of therapeutic tape in lateral epicondylalgia. Phys Ther Sport. 2019 Nov;40:117-127. doi: 10.1016/j.ptsp.2019.08.011. Epub 2019 Aug 27. PMID: 31518778.
BACKGROUND22. Landesa-Piñeiro L, Leirós-Rodríguez R. Physiotherapy treatment of lateral epicondylitis: A systematic review. J Back Musculoskelet Rehabil. 2022;35(3):463-477. doi: 10.3233/BMR-210053. PMID: 34397403.
BACKGROUND21. Torretta E, Moriggi M, Capitanio D, Orfei CP, Raffo V, Setti S, Cadossi R, de Girolamo L, Gelfi C. Effects of Pulsed Electromagnetic Field Treatment on Skeletal Muscle Tissue Recovery in a Rat Model of Collagenase-Induced Tendinopathy: Results from a Proteome Analysis. Int J Mol Sci. 2024 Aug 14;25(16):8852. doi: 10.3390/ijms25168852. PMID: 39201538; PMCID: PMC11354614.
BACKGROUND20. Wilms P, Schröder J, Scheit L, Reer R. Die Wirkung von elektromagnetischen Feldern auf Tendinopathien: Studie zur Effektanalyse einer singulären Anwendung von hochenergetischen gepulsten elektromagnetischen Feldern [The effect of electromagnetic fields on tendinopathies: Study on the effect analysis of a singular application of high-energy pulsed electromagnetic fields]. Orthopadie (Heidelb). 2024 Sep;53(9):668-676. German. doi: 10.1007/s00132-024-04541-3. Epub 2024 Aug 22. PMID: 39172175; PMCID: PMC11384642.
BACKGROUND19. Kim YJ, Wood SM, Yoon AP, Howard JC, Yang LY, Chung KC. Efficacy of Nonoperative Treatments for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2021 Jan 1;147(1):112-125. doi: 10.1097/PRS.0000000000007440. PMID: 33002980.
BACKGROUND18. Mascaró A, Cos MA, Morral A, Roig A, Purdam C, Cook J. Load management in tendinopathy: clinical progression for achilles and patellar tendinopathy. Original article. Apunts Med Esport. 2018;53 (197): 19-27.
BACKGROUND17. Yoon SY, Kim YW, Shin IS, Kang S, Moon HI, Lee SC. The Beneficial Effects of Eccentric Exercise in the Management of Lateral Elbow Tendinopathy: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Sep 1;10(17):3968. doi: 10.3390/jcm10173968. PMID: 34501416; PMCID: PMC8432114.
BACKGROUND16. Mollazehi N, Mohamadi M, Rezaeian S, Razeghi M. How effective is proprioception exercise on pain, grip force, dexterity and proprioception of elbow joint in patients with tennis elbow? A randomized controlled trial. J Bodyw Mov Ther. 2024 Oct;40:1821-1827. doi: 10.1016/j.jbmt.2024.10.035. Epub 2024 Oct 16. PMID: 39593530.
BACKGROUND15. Cullinane FL, Boocock MG, Trevelyan FC. Is eccentric exercise an effective treatment for lateral epicondylitis? A systematic review. Clin Rehabil. 2014 Jan;28(1):3-19. doi: 10.1177/0269215513491974. Epub 2013 Jul 23. PMID: 23881334.
BACKGROUND14. Yoon SY, Kim YW, Shin IS, Kang S, Moon HI, Lee SC. The Beneficial Effects of Eccentric Exercise in the Management of Lateral Elbow Tendinopathy: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Sep 1;10(17):3968. doi: 10.3390/jcm10173968. PMID: 34501416; PMCID: PMC8432114.
BACKGROUND13. Landesa-Piñeiro L, Leirós-Rodríguez R. Physiotherapy treatment of lateral epicondylitis: A systematic review. J Back Musculoskelet Rehabil. 2022;35(3):463-477. doi: 10.3233/BMR-210053. PMID: 34397403.
BACKGROUND12. Wood SM, Yoon AP, Tseng HJ, Yang LY, Chung KC. Comparative Effectiveness of Physical Therapy and Electrophysiotherapy for the Treatment of Lateral Epicondylitis: A Network Meta-Analysis. Plast Reconstr Surg. 2022 Sep 1;150(3):594e-607e. doi: 10.1097/PRS.0000000000009437. Epub 2022 Jul 1. PMID: 35791264.
BACKGROUND11. Sipers, W. M. W. H., Verdijk, L. B., Sipers, S. J. E., Schols, J. M. G. A., & van Loon, L. J. C. (2016). The Martin Vigorimeter Represents a Reliable and More Practical Tool Than the Jamar Dynamometer to Assess Handgrip Strength in the Geriatric Patient. Journal of the American Medical Directors Association, 17(5), 466.e1-466.e7. https://doi.org/10.1016/j.jamda.2016.02.026.
BACKGROUND10. Soares MM, Souza PC, Ribeiro AP. Differences in Clinical Tests for Assessing Lateral Epicondylitis Elbow in Adults Concerning Their Physical Activity Level: Test Reliability, Accuracy of Ultrasound Imaging, and Relationship with Energy Expenditure. Int J Environ Res Public Health. 2023 Jan 18;20(3):1794. doi: 10.3390/ijerph20031794. PMID: 36767167; PMCID: PMC9914816.
BACKGROUND9. Chesterton LS, Sim J, Wright CC, Foster NE. Interrater Reliability of Algometry in Measuring Pressure Pain Thresholds in Healthy Humans, Using Multiple Raters. Clin J Pain. noviembre de 2007;23(9).
BACKGROUND8. Navarro-Santana MJ, Sanchez-Infante J, Gómez-Chiguano GF, Cummings M, Fernández-de-Las-Peñas C, Plaza-Manzano G. Effects of manual acupuncture and electroacupuncture for lateral epicondylalgia of musculoskeletal origin: a systematic review and meta-analysis. Acupunct Med. 2021 Oct;39(5):405-422. doi: 10.1177/0964528420967364. Epub 2020 Dec 17. PMID: 33334116.
BACKGROUND7. Kim YJ, Wood SM, Yoon AP, Howard JC, Yang LY, Chung KC. Efficacy of Nonoperative Treatments for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2021 Jan 1;147(1):112-125. doi: 10.1097/PRS.0000000000007440. PMID: 33002980.
BACKGROUND6. Bretschneider SF, Los FS, Eygendaal D, Kuijer PPFM, van der Molen HF. Work-relatedness of lateral epicondylitis: Systematic review including meta-analysis and GRADE work-relatedness of lateral epicondylitis. Am J Ind Med. 2022 Jan;65(1):41-50. doi: 10.1002/ajim.23303. Epub 2021 Oct 21. PMID: 34674287; PMCID: PMC9297967.
BACKGROUND5. Lenoir H, Mares O, Carlier Y. Management of lateral epicondylitis. Orthop Traumatol Surg Res. 2019 Dec;105(8S): S241-S246. doi: 10.1016/j.otsr.2019.09.004. Epub 2019 Sep 19. PMID: 31543413.
BACKGROUND4. Di Filippo L, Vincenzi S, Pennella D, Maselli F. Treatment, Diagnostic Criteria and Variability of Terminology for Lateral Elbow Pain: Findings from an Overview of Systematic Reviews. Healthcare (Basel). 2022 Jun 14;10(6):1095. doi: 10.3390/healthcare10061095. PMID: 35742152; PMCID: PMC9222841.
BACKGROUND3. Monge Pelegrín E, Garín Portero N. Abordaje de la epicondilitis. Exploración y tratamiento. RSI. Fisioterapia. 26 septiembre 2021. https://revistasanitariadeinvestigacion.com/category/fisioterapia.
BACKGROUND2. Uttamchandani SR, Phansopkar P. Conservative Management of Lateral Epicondylalgia: A Review. Cureus. 2024 May 8;16(5): e59875. doi: 10.7759/cureus.59875. PMID: 38854316; PMCID: PMC11157989.
BACKGROUND1. Vinhas A, Almeida AF, Rodrigues MT, Gomes ME. Prospects of magnetically based approaches addressing inflammation in tendon tissues. Adv Drug Deliv Rev. 2023 May;196:114815. doi: 10.1016/j.addr.2023.114815. Epub 2023 Mar 30. PMID: 37001644.
BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anna Escribà Salvans
Universitat de Vic, Universitat Central de Catalunya (UVIC-UCC)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants, the principal investigator, and the outcomes assessors are blinded to group allocation. Randomization is managed through opaque sequentially numbered envelopes. Only the physical therapists delivering the interventions have access to the randomization sequence.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, PhD
Study Record Dates
First Submitted
March 3, 2026
First Posted
March 27, 2026
Study Start
March 30, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- IPD and supporting documents will be available starting in January 2027 and will remain available with no planned end date.
- Access Criteria
- Access to IPD and supporting documentation will be granted to qualified researchers who request the data for legitimate scientific purposes and submit a proposal with a sound methodological approach and ethical rationale. Data will be provided in a fully de-identified format, along with relevant supporting documents when appropriate, and will be shared through secure transfer procedures to ensure participant confidentiality. Requests should be submitted to the Principal Investigator and will be evaluated on a case-by-case basis in accordance with applicable ethical and legal regulations. Data use will not be permitted for any purpose that could compromise participant privacy or well-being.
Individual Participant Data (IPD) from this study will be available to qualified researchers upon reasonable request. Data will be shared in a de-identified format to protect participant confidentiality and will be provided through secure transfer procedures. Access will be granted to investigators who submit a methodologically sound proposal and a clear scientific rationale. Requests may be directed to the Principal Investigator and will be evaluated on a case-by-case basis in accordance with ethical and regulatory requirements.